Two years into the pandemic, unequal access to COVID-19 treatments threatens the global recovery
It's now two years since the World Health Organization began calling the COVID-19 outbreak a pandemic.
Mar 14, 2022
0
3
It's now two years since the World Health Organization began calling the COVID-19 outbreak a pandemic.
Mar 14, 2022
0
3
For adolescents aged 12 to 17 years, reactions to homologous Pfizer-BioNTech booster vaccination occur with similar frequency as after receipt of the second vaccine dose, and they are generally mild to moderate in severity, ...
Mar 4, 2022
0
2
Pfizer's new COVID-19 treatment came with a catch when it debuted late last year: Supplies were limited, and it can take months to make the tablets.
Mar 2, 2022
0
3
(HealthDay)—After you have recovered from COVID-19, getting at least one dose of a vaccine provides added protection against reinfection, Israeli researchers report.
Feb 17, 2022
2
101
(HealthDay)—The U.S. Food and Drug Administration announced Friday that it will postpone an advisory panel meeting that was slated for next week to weigh Pfizer's COVID vaccine for use in young children.
Feb 14, 2022
0
6
COVID-19 vaccinations for children under 5 hit another monthslong delay Friday as U.S. regulators abruptly put the brakes on their efforts to speed review of the shots that Pfizer is testing for youngsters.
Feb 11, 2022
0
8
Adolescents aged 16 to 17 are now eligible to receive their Pfizer vaccine booster, following the recommendation earlier this week from the Australian Technical Advisory Group on Immunisation (ATAGI).
Feb 4, 2022
0
2
Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.
Feb 1, 2022
0
2
Pfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots.
Jan 25, 2022
0
75
A booster dose of the Pfizer–BioNTech vaccine (BNT162b2) against SARS-CoV-2 after an initial two doses of either the CoronaVac inactivated virus vaccine or Pfizer–BioNTech mRNA vaccine is shown to provide protection against ...
Jan 24, 2022
0
27